Patent · US Active

Aflatoxin M1 nanobody 2014AFM-G2

US9128089B1 · kind B1 · utility

1Cited by

0References

5Claims

0Family size

Assignee

OILCROPS RESEARCH INSTITUTE OF CHINESE ACADAMY OF AGRICULTURE SCIENCES · CN

Inventors

Peiwu Li · Hubei, CN
Ting He · Dublin, US
Qi Zhang · Beijing, CN
Zhaowei Zhang · Hubei, CN
Xiaoxia Ding · Hubei, CN

Key dates

Filing date	Mar 24, 2015
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Mar 24, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2469/10
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Aflatoxin M1 nanobody 2014AFM-G2 has the amino acid sequence of SEQ ID NO:7, and is encoded by the gene sequence of SEQ ID NO:8. The aflatoxin M1 nanobody 2014AFM-G2 obtained via screening has the properties of tolerance to organic reagents, tolerance to high temperature, tolerance to acids and bases and the like, and good stability. The aflatoxin M1 nanobody 2014AFM-G2 has 50% inhibiting concentration IC50 to aflatoxin M1 of 0.208 ng/mL, and has cross reaction rates with aflatoxin B1, B2, G1, G2 are 9.43%, 5.93%, 4.87% and 6.17%, respectively.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.